China Biologic Reports Financial Results for the First Quarter of 2019

Saturday, May 11, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES 

For the Three Months Ended

March 31,

March 31,

2019

2018

USD

USD

Income from Operations

43,886,978

38,973,963

Non-cash employee share-based compensation

6,305,967

9,009,234

Amortization of acquired intangible assets and land use rights

2,055,032

2,157,302

Adjusted Income from Operations - Non GAAP

52,247,977

50,140,499

Net Income Attributable to the Company

37,692,106

31,585,077

Non-cash employee share-based compensation

5,450,091

8,262,637

Amortization of acquired intangible assets and land use rights

1,397,422

1,466,965

Adjusted Net Income Attributable to the Company - Non GAAP

44,539,619

41,314,679

Diluted EPS - Non GAAP

1.11

1.21

Weighted average number of shares used in computation of Non GAAP diluted EPS

39,412,441

33,338,470



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store